Measuring empowerment in patients with psoriasis: The psoriasis empowerment enquiry in the routine practice (PEER) questionnaire

Calogero Pagliarello, Cristina Di Pietro, Andrea Paradisi, Damiano Abeni, Stefano Tabolli

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

While empowerment is an outcome pursued by advocacy groups and health care providers, no data are yet available about empowerment in patients with psoriasis in the literature. Our aim was to develop a tool for measuring levels of empowerment in psoriatic patients, and to assess its validity and reliability. A cross-sectional study among outpatients with psoriasis was carried out. Principal component analysis was performed to validate the questionnaire and to measure any associations with demographic and clinical data. The 12-item questionnaire (Psoriasis Empowerment Enquiry in the Routine practice, or PEER) showed acceptable consistency and reliability, and three distinct and interpretable factors have been identified: Knowledge, Experience, Skills. Patients older than 44 years and patients with psoriasis for more than one year showed statistically significantly higher levels of empowerment. Neither educational level nor the number of consultations influenced the global empowerment score (GES). A link between GES and prescribed therapy was found, suggesting that patients receiving systemic drugs have better knowledge, more insight and superior skills to manage their psoriasis. We conclude that PEER is an appropriate tool to assess empowerment among patients with psoriasis and may be used to evaluate the efficacy of educational interventions. Further studies are needed to assess its convergent validity and to improve its reliability.

Original languageEnglish
Pages (from-to)200-204
Number of pages5
JournalEuropean Journal of Dermatology
Volume20
Issue number2
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Patient Participation
Psoriasis
Surveys and Questionnaires
Power (Psychology)
Principal Component Analysis
Reproducibility of Results
Health Personnel
Outpatients
Referral and Consultation
Cross-Sectional Studies
Demography

Keywords

  • Empowerment
  • Health services
  • Outcome measure
  • Psoriasis
  • Therapy adherence

ASJC Scopus subject areas

  • Dermatology

Cite this

Measuring empowerment in patients with psoriasis : The psoriasis empowerment enquiry in the routine practice (PEER) questionnaire. / Pagliarello, Calogero; Di Pietro, Cristina; Paradisi, Andrea; Abeni, Damiano; Tabolli, Stefano.

In: European Journal of Dermatology, Vol. 20, No. 2, 03.2010, p. 200-204.

Research output: Contribution to journalArticle

Pagliarello, Calogero ; Di Pietro, Cristina ; Paradisi, Andrea ; Abeni, Damiano ; Tabolli, Stefano. / Measuring empowerment in patients with psoriasis : The psoriasis empowerment enquiry in the routine practice (PEER) questionnaire. In: European Journal of Dermatology. 2010 ; Vol. 20, No. 2. pp. 200-204.
@article{bad921ee7bb64f3e877cacdb2efcebe1,
title = "Measuring empowerment in patients with psoriasis: The psoriasis empowerment enquiry in the routine practice (PEER) questionnaire",
abstract = "While empowerment is an outcome pursued by advocacy groups and health care providers, no data are yet available about empowerment in patients with psoriasis in the literature. Our aim was to develop a tool for measuring levels of empowerment in psoriatic patients, and to assess its validity and reliability. A cross-sectional study among outpatients with psoriasis was carried out. Principal component analysis was performed to validate the questionnaire and to measure any associations with demographic and clinical data. The 12-item questionnaire (Psoriasis Empowerment Enquiry in the Routine practice, or PEER) showed acceptable consistency and reliability, and three distinct and interpretable factors have been identified: Knowledge, Experience, Skills. Patients older than 44 years and patients with psoriasis for more than one year showed statistically significantly higher levels of empowerment. Neither educational level nor the number of consultations influenced the global empowerment score (GES). A link between GES and prescribed therapy was found, suggesting that patients receiving systemic drugs have better knowledge, more insight and superior skills to manage their psoriasis. We conclude that PEER is an appropriate tool to assess empowerment among patients with psoriasis and may be used to evaluate the efficacy of educational interventions. Further studies are needed to assess its convergent validity and to improve its reliability.",
keywords = "Empowerment, Health services, Outcome measure, Psoriasis, Therapy adherence",
author = "Calogero Pagliarello and {Di Pietro}, Cristina and Andrea Paradisi and Damiano Abeni and Stefano Tabolli",
year = "2010",
month = "3",
doi = "10.1684/ejd.2010.0893",
language = "English",
volume = "20",
pages = "200--204",
journal = "European Journal of Dermatology",
issn = "1167-1122",
publisher = "NLM (Medline)",
number = "2",

}

TY - JOUR

T1 - Measuring empowerment in patients with psoriasis

T2 - The psoriasis empowerment enquiry in the routine practice (PEER) questionnaire

AU - Pagliarello, Calogero

AU - Di Pietro, Cristina

AU - Paradisi, Andrea

AU - Abeni, Damiano

AU - Tabolli, Stefano

PY - 2010/3

Y1 - 2010/3

N2 - While empowerment is an outcome pursued by advocacy groups and health care providers, no data are yet available about empowerment in patients with psoriasis in the literature. Our aim was to develop a tool for measuring levels of empowerment in psoriatic patients, and to assess its validity and reliability. A cross-sectional study among outpatients with psoriasis was carried out. Principal component analysis was performed to validate the questionnaire and to measure any associations with demographic and clinical data. The 12-item questionnaire (Psoriasis Empowerment Enquiry in the Routine practice, or PEER) showed acceptable consistency and reliability, and three distinct and interpretable factors have been identified: Knowledge, Experience, Skills. Patients older than 44 years and patients with psoriasis for more than one year showed statistically significantly higher levels of empowerment. Neither educational level nor the number of consultations influenced the global empowerment score (GES). A link between GES and prescribed therapy was found, suggesting that patients receiving systemic drugs have better knowledge, more insight and superior skills to manage their psoriasis. We conclude that PEER is an appropriate tool to assess empowerment among patients with psoriasis and may be used to evaluate the efficacy of educational interventions. Further studies are needed to assess its convergent validity and to improve its reliability.

AB - While empowerment is an outcome pursued by advocacy groups and health care providers, no data are yet available about empowerment in patients with psoriasis in the literature. Our aim was to develop a tool for measuring levels of empowerment in psoriatic patients, and to assess its validity and reliability. A cross-sectional study among outpatients with psoriasis was carried out. Principal component analysis was performed to validate the questionnaire and to measure any associations with demographic and clinical data. The 12-item questionnaire (Psoriasis Empowerment Enquiry in the Routine practice, or PEER) showed acceptable consistency and reliability, and three distinct and interpretable factors have been identified: Knowledge, Experience, Skills. Patients older than 44 years and patients with psoriasis for more than one year showed statistically significantly higher levels of empowerment. Neither educational level nor the number of consultations influenced the global empowerment score (GES). A link between GES and prescribed therapy was found, suggesting that patients receiving systemic drugs have better knowledge, more insight and superior skills to manage their psoriasis. We conclude that PEER is an appropriate tool to assess empowerment among patients with psoriasis and may be used to evaluate the efficacy of educational interventions. Further studies are needed to assess its convergent validity and to improve its reliability.

KW - Empowerment

KW - Health services

KW - Outcome measure

KW - Psoriasis

KW - Therapy adherence

UR - http://www.scopus.com/inward/record.url?scp=77950400897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950400897&partnerID=8YFLogxK

U2 - 10.1684/ejd.2010.0893

DO - 10.1684/ejd.2010.0893

M3 - Article

C2 - 20167566

AN - SCOPUS:77950400897

VL - 20

SP - 200

EP - 204

JO - European Journal of Dermatology

JF - European Journal of Dermatology

SN - 1167-1122

IS - 2

ER -